1cP-AL-LAD

1cP-AL-LAD
Clinical data
Routes of
administration
Oral
Drug classSerotonergic psychedelic; Hallucinogen
Pharmacokinetic data
Duration of action7–10 hours
Identifiers
  • (6aR,9R)-4-(cyclopropanecarbonyl)-N,N-diethyl-7-prop-2-enyl-6,6a,8,9-tetrahydroindolo[4,3-fg]quinoline-9-carboxamide
CAS Number
PubChem CID
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC26H31N3O2
Molar mass417.553 g·mol−1
3D model (JSmol)
  • CCN(CC)C(=O)[C@@H]1C=C2[C@@H](Cc3cn(C(=O)C4CC4)c4cccc2c34)N(C1)CC=C
  • InChI=1S/C26H31N3O2/c1-4-12-28-15-19(25(30)27(5-2)6-3)13-21-20-8-7-9-22-24(20)18(14-23(21)28)16-29(22)26(31)17-10-11-17/h4,7-9,13,16-17,19,23H,1,5-6,10-12,14-15H2,2-3H3/t19-,23-/m1/s1
  • Key:VSABTUDYQCMWKE-AUSIDOKSSA-N

1cP-AL-LAD is a psychedelic drug of the lysergamide family related to lysergic acid diethylamide (LSD). It is thought to act as prodrug of AL-LAD. The drug has been encountered as a novel designer drug.